Physician profile
Thomas E Hamilton
NPI 1053349555
$2,800.56
in general payments reported to CMS, 2019-2025
25 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $831 · 2020: $448 · 2021: $267 · 2022: $524 · 2023: $426 · 2024: $105 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $731.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $758.87 | 2019-2023 | Speedicath, Titan |
| Medtronic USA, INC. | $512.91 | 2019 | |
| Boston Scientific Corporation | $245.28 | 2022-2025 | Solyx Sis System, General - Pelvic Organ Prolapse |
| Janssen Biotech, INC. | $213.19 | 2019-2023 | Erleada |
| Abbvie INC. | $189.00 | 2019-2023 | |
| Astellas Pharma US INC | $160.44 | 2019-2023 | Myrbetriq |
| Neotract INC. | $107.94 | 2019-2020 | |
| Medtronic, INC. | $102.26 | 2021-2025 | Interstim |
| Bioprotect Medical, INC. | $90.87 | 2024 | Bioprotect Balloon Implant System |
| Bayer Healthcare Pharmaceuticals INC. | $83.51 | 2022 | |
| Laborie Medical Technologies Corp. | $49.10 | 2020 | |
| Allergan, INC. | $38.44 | 2020-2022 | |
| Antares Pharma, INC. | $34.01 | 2020-2022 | |
| Pfizer INC. | $26.98 | 2019 | |
| Olympus America INC. | $22.20 | 2023 | Itind System |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clarus Therapeutics INC. | $21.49 | 2021 | |
| Merck Sharp & Dohme LLC | $21.23 | 2022 | |
| Sumitomo Pharma America, INC. | $19.16 | 2023 | Gemtesa |
| Ambu INC. | $18.11 | 2021-2023 | |
| Teleflex LLC | $17.47 | 2023 | Urolift |
| Endo Pharmaceuticals INC. | $17.05 | 2019 | |
| Urogen Pharma, INC. | $15.86 | 2023 | Jelmyto |
| Rgh Enterprises LLC | $12.35 | 2019 | |
| Acerus Pharmaceuticals Corporation | $11.77 | 2022 | |
| Hikma Pharmaceuticals USA | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Hamilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.